How physician obesity specialists use drugs to treat obesity (Q37418915)

20 August 2017

How physician obesity specialists use drugs to treat obesity (English)

1 reference

20 August 2017

0 references

3

Frank L Greenway

1 reference

20 August 2017

Ed J Hendricks

1

1 reference

PubMed ID

19300434

20 August 2017

Richard B Rothman

series ordinal

2

1 reference

20 August 2017

19 March 2009

1 reference

20 August 2017

1 reference

20 August 2017

17

1 reference

20 August 2017

1730-1735

1 reference

20 August 2017

9

1 reference

Meta-analysis: pharmacologic treatment of obesity

20 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Pharmacological treatment of the overweight patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

The long-term management of obesity with continuing pharmacotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

Arterial intima-media thickness in 13-year-old adolescents and previous antichlamydial antimicrobial use: a retrospective follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.69

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.69

1 reference

20 August 2017

1 reference

PubMed ID

19300434